PharmaBoardroom

Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights the incredible progress of COVID-19…

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…

The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…

Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…

The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox in 1976 by injecting them with…

The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in real terms (inflation adjusted),…

While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the pharmaceutical industry, vaccines are also…

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…

Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…

2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning…

The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national COVID-19 vaccination programs, a…

Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines. Moreover, vaccines are an important…